1995
DOI: 10.1006/bbrc.1995.2626
|View full text |Cite
|
Sign up to set email alerts
|

Non-oxidative Loss of Glutathione in Apoptosis via GSH Extrusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

9
109
0
3

Year Published

2000
2000
2013
2013

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 180 publications
(121 citation statements)
references
References 0 publications
9
109
0
3
Order By: Relevance
“…In fact, cisplatin treatment induces a dramatic GSH depletion in frankly apoptotic cells, while such depletion is much less evident in still adhering cells at 48 h and even absent at 24 h (Table 1). A marked depletion of intracellular GSH has been described in a number of different models of apoptosis (Ghibelli et al, 1995;Macho et al, 1997), where GSH loss is consequent to an accelerated efflux via specific GSH carriers (Van den Dobbelsteen et al, 1996;Ghibelli et al, 1998;Trompier et al, 2004 To confirm calpain activation in cisplatin-treated cells and to gain information about the population of frankly apoptotic cells, we carried out the same test in intact cells using a fluorescent substrate: N-succ-Leu-Tyr-AMC (Succ) (Figure 1b). We obtained very similar results, confirming a significant increase of calpain activity at 48 h in still adhering cells, which is even more evident in detached cells.…”
Section: Calpain Activity Is Increased Early In Preapoptotic Cellsmentioning
confidence: 99%
“…In fact, cisplatin treatment induces a dramatic GSH depletion in frankly apoptotic cells, while such depletion is much less evident in still adhering cells at 48 h and even absent at 24 h (Table 1). A marked depletion of intracellular GSH has been described in a number of different models of apoptosis (Ghibelli et al, 1995;Macho et al, 1997), where GSH loss is consequent to an accelerated efflux via specific GSH carriers (Van den Dobbelsteen et al, 1996;Ghibelli et al, 1998;Trompier et al, 2004 To confirm calpain activation in cisplatin-treated cells and to gain information about the population of frankly apoptotic cells, we carried out the same test in intact cells using a fluorescent substrate: N-succ-Leu-Tyr-AMC (Succ) (Figure 1b). We obtained very similar results, confirming a significant increase of calpain activity at 48 h in still adhering cells, which is even more evident in detached cells.…”
Section: Calpain Activity Is Increased Early In Preapoptotic Cellsmentioning
confidence: 99%
“…In addition, alterations in its concentration have been demonstrated as a common feature of many pathological situations including AIDS, neurodegenerative diseases, and cancer (9,10). Intracellular GSH loss is an early hallmark in the progression of cell death in response to different apoptotic stimuli (11)(12)(13)(14), and has been associated with the activation of a plasma membrane transport mechanism rather than to its oxidation (11)(12)(13)(15)(16)(17). Furthermore, several studies have shown a correlation between cellular GSH depletion and the progression of apoptosis (12,13).…”
mentioning
confidence: 99%
“…On the other hand, ROS also have an important function in pro-apoptotic pathways (Curtin et al, 2002;Matsuzawa and Ichijo, 2005). As intracellular redox status is critical in determining the survival and death of cells (Hampton and Orrenius, 1998), many cancer therapeutics target to induce cellular apoptosis by disrupting the redox balance and depleting the intracellular thiol buffer system through extrusion or redistribution of glutathione (GSH) (Ghibelli et al, 1995).…”
mentioning
confidence: 99%